Taylor Andrew Lawrence
- SEC CIK
- 0001723889
No open-market purchases or sales filed in the past year.
Current role at each company
- OBIO Orchestra BioMed Holdings, Inc.Chief Financial Officeras of Aug 28, 2026
- MOTS Motus GI Holdings, Inc.Chief Financial Officeras of Feb 11, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Taylor Andrew Lawrence as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
OBIO Orchestra BioMed Holdings, Inc.
Chief Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2025 (view filing) | Aug 25 | Same day | Taylor Andrew LawrenceChief Financial Officer | PPurchaseCommon Stock, par value $0.0001 per share | +2.00K | $2.55 | +$5.10K | +0.4%482.8K after | |
| Dec 20, 2024 (view filing) | Dec 19 | 1 day | Taylor Andrew LawrenceChief Financial Officer | PPurchaseCommon Stock, par value $0.0001 per share | +1.00K | $4.83 | +$4.83K | +0.3%345.0K after |
MOTS Motus GI Holdings, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2021 (view filing) | Nov 19 | 3 days | Taylor Andrew LawrenceChief Financial Officer | PPurchaseCommon Stock, par value $0.0001 per share | +2.00K | $0.51 | +$1.02K | +1.5%135.7K after |